Lee HS, Jeon SW. Barrett esophagus in Asia: same disease with different pattern. Clin Endosc. 2014;47:15–22.
Chandrasekar VT, Hamade N, Desai M, et al. Significantly lower annual rates of neoplastic progression in short-compared to long-segment non-dysplastic Barrett’s esophagus: a systematic review and meta-analysis. Endoscopy. 2019;51:665–72.
Iwakiri K, Fujiwara Y, Manabe N, et al. Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2021. J Gastroenterol. 2022;57:267–85.
Sato H, Terai S, Shimamura Y, et al. Achalasia and esophageal cancer: a large database analysis in Japan. J Gastroenterol. 2021;56:360–70.
Shaheen NJ, Richter JE. Barrett’s oesophagus. Lancet. 2009;373:850–61.
Shiwaku H, Sato H, Shimamura Y, et al. Risk factors and long-term course of gastroesophageal reflux disease after peroral endoscopic myotomy: a large-scale multicenter cohort study in Japan. Endoscopy. 2022. (in press).
Shaheen NJ, Falk GW, Iyer PG, et al. Diagnosis and management of Barrett’s Esophagus: an updated ACG guideline. Am J Gastroenterol. 2022;117:559–87.
Fitzgerald RC, di Pietro M, Ragunath K, et al. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett’s oesophagus. Gut. 2014;63:7–42.
ASGE STANDARDS OF PRACTICE COMMITTEE, Qumseya B, Sultan S, et al. ASGE guideline on screening and surveillance of Barrett’s esophagus. Gastrointest Endosc. 2019;90:335-359.e2.
Sato H, Nishikawa Y, Abe H, et al. Esophageal carcinoma in achalasia patients managed with endoscopic submucosal dissection and peroral endoscopic myotomy: Japan Achalasia Multicenter Study. Dig Endosc. 2022;34:965–73.
留言 (0)